Trial Profile
The Effect of Sevelamer Carbonate on Critical Variables in the Pathogenesis of Secondary Hyperparathyroidism
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Sevelamer (Primary)
- Indications Hyperphosphataemia
- Focus Pharmacodynamics
- 12 Dec 2015 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health; NCT01191762).
- 07 Dec 2015 New trial record